false
0000895421
0000895421
2026-06-24
2026-06-24
0000895421
us-gaap:CommonClassAMember
2026-06-24
2026-06-24
0000895421
us-gaap:SeriesAPreferredStockMember
2026-06-24
2026-06-24
0000895421
us-gaap:SeriesEPreferredStockMember
2026-06-24
2026-06-24
0000895421
us-gaap:SeriesFPreferredStockMember
2026-06-24
2026-06-24
0000895421
MS:SeriesIPreferredStockMember
2026-06-24
2026-06-24
0000895421
MS:SeriesKPreferredStockMember
2026-06-24
2026-06-24
0000895421
MS:SeriesLPreferredStockMember
2026-06-24
2026-06-24
0000895421
MS:SeriesOPreferredStockMember
2026-06-24
2026-06-24
0000895421
MS:SeriesPPreferredStockMember
2026-06-24
2026-06-24
0000895421
MS:SeriesQPreferredStockMember
2026-06-24
2026-06-24
0000895421
MS:GlobalMediumTermNotesSeriesAFloatingRateNotesDue2029ofMorganStanleyFinanceLLCMember
2026-06-24
2026-06-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
June 24, 2026
Morgan Stanley
(Exact Name of Registrant
as Specified in Charter)
| Delaware |
1-11758 |
36-3145972 |
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 1585 Broadway, New York, New York |
|
10036 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (212) 761-4000
Not Applicable
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common Stock, $0.01 par value |
MS |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of Floating Rate
Non-Cumulative Preferred Stock, Series A,
$0.01 par value |
MS/PA |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series E,
$0.01 par value |
MS/PE |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series F,
$0.01 par value |
MS/PF |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series I,
$0.01 par value |
MS/PI |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series K,
$0.01 par value |
MS/PK |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of 4.875%
Non-Cumulative Preferred Stock, Series L,
$0.01 par value |
MS/PL |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of 4.250%
Non-Cumulative Preferred Stock, Series O,
$0.01 par value |
MS/PO |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of 6.500%
Non-Cumulative Preferred Stock, Series P,
$0.01 par value |
MS/PP |
New York Stock Exchange |
|
Depositary Shares, each representing 1/1,000th
interest in a share of 6.625%
Non-Cumulative Preferred Stock, Series Q,
$0.01 par value |
MS/PQ |
New York Stock Exchange |
|
Global Medium-Term Notes, Series A, Floating
Rate Notes Due 2029
of Morgan Stanley Finance LLC (and Registrant’s
guarantee with respect thereto) |
MS/29 |
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On June 24, 2026, Morgan Stanley
(the “Company”) announced it will increase its quarterly common stock dividend to $1.15 per share from the current $1.00
per share, beginning with the common stock dividend expected to be declared by the Company’s Board of Directors (the “Board”)
in the quarter ending September 30, 2026 (the “third quarter”). In addition, the Board reauthorized a multi-year common equity
share repurchase program of up to $20 billion, without a set expiration date, beginning in the third quarter. The share repurchases
will be exercised from time to time at prices the Company deems appropriate, subject to various considerations, including current market
conditions, the Company’s capital position and future economic and earnings outlook.
On June 24, 2026, the Board of Governors
of the Federal Reserve System (the “Federal Reserve”) published summary results of its 2026 supervisory stress tests, which
do not impact the Company’s Stress Capital Buffer (“SCB”) requirement. On February 4, 2026, the Federal Reserve announced
that it expects the Company will continue to be subject to its current SCB requirement of 4.3% until October 1, 2027, at which time a
new SCB requirement may apply based on the results of the supervisory stress test conducted in 2027.
A copy of the press release relating
to this announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Forward-Looking Statements
This Current Report on Form 8-K (including
the Exhibit hereto) contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of
the date on which they are made, which reflect management’s current estimates, projections, expectations, assumptions, interpretations
or beliefs of the Company’s future results, regulatory capital levels and future capital actions, including common stock dividends
and common equity share repurchases, and which are subject to risks and uncertainties that may cause actual results to differ materially.
The Company does not undertake to update the forward-looking statements to reflect the impact of circumstances or events that may arise
after the date of forward-looking statements. For a discussion of additional risks and uncertainties that may affect the future results,
regulatory capital levels and future capital actions of the Company, please see “Forward-Looking Statements” preceding Part
I, Item 1, “Competition” and “Supervision and Regulation” in Part I, Item 1, “Risk Factors” in Part
I, Item 1A, “Legal Proceedings” in Part I, Item 3, “Management’s Discussion and Analysis of Financial Condition
and Results of Operations” in Part II, Item 7 and “Quantitative and Qualitative Disclosures about Risk” in Part II,
Item 7A, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and other items throughout the Form 10-K,
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments thereto.
| Item 9.01. |
|
Financial Statements and Exhibits. |
| (d) |
|
Exhibits |
| Exhibit |
|
|
| Number |
|
Description |
| 99.1 |
|
Press Release of the Company, dated June 24, 2026. |
| 101 |
|
Interactive Data Files pursuant to Rule 406 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBL”). |
| 104 |
|
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). |
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| |
|
MORGAN STANLEY
(Registrant) |
| |
|
|
| Date: |
June 24, 2026 |
|
By: |
/s/ Martin M. Cohen |
| |
|
|
|
Name: |
Martin M. Cohen |
| |
|
|
|
Title: |
Corporate Secretary |
Exhibit 99.1
 |
FOR IMMEDIATE RELEASE
|
June 24, 2026
Morgan Stanley Announces a Dividend Increase of 15 Cents to
$1.15 Per Share and the Reauthorization of a $20 Billion Multi-Year Common Equity Share Repurchase Program
NEW YORK - Morgan Stanley
(NYSE: MS) announced that it will increase its quarterly common stock dividend to $1.15 per share from the current $1.00 per share,
beginning with the common stock dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2026.
In addition, the Firm’s Board of Directors reauthorized a multi-year
common equity share repurchase program of up to $20 billion, without a set expiration date, beginning in the third quarter of 2026.
The share repurchases will be exercised from time to time at prices the Firm deems appropriate, subject to various considerations, including
current market conditions, the Firm’s capital position and future economic and earnings outlook.
Ted Pick, Chairman and Chief Executive Officer of Morgan Stanley, said,
“We have a globally scaled business that supports the Firm’s durable returns and strong capital position. Our financial strength
gives us ongoing flexibility to invest in growth opportunities across the Integrated Firm while increasing the return of capital to shareholders.”
On June 24, 2026, the Board of Governors of the Federal Reserve System
released its CCAR 2026 results which do not impact the Firm’s Stress Capital Buffer (SCB) requirement. On February 4, 2026, the
Federal Reserve announced that it expects the Firm will continue to be subject to its current SCB requirement of 4.3% until October 1,
2027, at which time a new SCB requirement may apply based on the results of the supervisory stress test conducted in 2027. Together with
other features of the regulatory capital framework, this SCB results in an aggregate U.S. Basel III Standardized Approach Common Equity
Tier 1 (CET1) ratio of 11.8%. The Firm’s U.S. Basel III Standardized Approach CET1 ratio was 15.1% as of March 31, 2026.
Morgan Stanley is a leading global financial services firm providing
a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the
Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For further information
about Morgan Stanley, please visit www.morganstanley.com.
Forward-Looking Statements
This Release contains forward-looking statements within the meaning
of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance
on forward-looking statements, which speak only as of the date on which they are made, which reflect management’s current estimates,
projections, expectations, assumptions, interpretations or beliefs of Morgan Stanley’s future results, regulatory capital levels
and future capital actions, including common stock dividends and common equity share repurchases, and which are subject to risks and uncertainties
that may cause actual results to differ materially. Morgan Stanley does not undertake to update the forward-looking statements to reflect
the impact of circumstances or events that may arise after the date of forward-looking statements. For a discussion of additional risks
and uncertainties that may affect the future results, regulatory capital levels and future capital actions of Morgan Stanley, please see
“Forward-Looking Statements” preceding Part I, Item 1, “Competition” and “Supervision and Regulation”
in Part I, Item 1, “Risk Factors” in Part I, Item 1A, “Legal Proceedings” in Part I, Item 3, “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 and “Quantitative and Qualitative
Disclosures about Risk” in Part II, Item 7A, in Morgan Stanley’s Annual Report on Form 10-K for the year ended December 31,
2025 and other items throughout the Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments
thereto.
###
| Media Relations: Wesley McDade, 212.761.2430 |
Investor Relations: Leslie Bazos, 212.761.5352 |